Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.

CONCLUSIONS: Pre-diagnosis MHT use for 5+ years was a favorable prognostic factor for women with ovarian cancer. This large study is consistent with prior smaller studies, and further work is needed to understand the underlying mechanism.
PMID: 32641237 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - July 4, 2020 Category: Cancer & Oncology Authors: Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, Doherty JA, Fortner RT, Garsed DW, Gayther SA, Gentry-Maharaj A, Goo Tags: Gynecol Oncol Source Type: research